Breast Cancer Clinical Trials in Houston, TX

Breast Cancer Clinical Trials in Houston, TX

View the best 10 breast cancer medical studies in Houston, Texas. Access promising new therapies by applying to a Houston-based Breast Cancer clinical trial.

Trials in Houston, Texas

Here are the top 10 medical studies for breast cancer in Houston, Texas

Image of University of South Alabama - Mitchell Cancer Institute in Mobile, United States.

T-DM1 +1 More

Antibody Drug Conjugate

Recruiting1 awardPhase 3
This trial is being done to see if adding tucatinib to T-DM1 helps patients with HER2 positive breast carcinoma.
Image of St. Joseph's Hospital and Medical Center in Phoenix, United States.

Fulvestrant +1 More

Estrogen Receptor Antagonist

Recruiting1 awardPhase 3
This trial is testing a combination of two drugs, abemaciclib and fulvestrant, for treating a specific type of breast cancer that has not responded to previous treatments. Abemaciclib is taken orally and is approved for treating certain types of breast cancer. The goal is to see if this combination can help stop the cancer from growing. The study may last several years, depending on how well the treatment works for each patient.
Image of Banner MD Anderson Cancer Center in Gilbert, United States.

LY3484356

Immunotherapy

Recruiting1 awardPhase 1
This trial will test if a new drug is safe and effective for treating people with advanced breast or endometrial cancer.
Image of Northwest Georgia Oncology Centers PC - Marietta in Marietta, United States.

Giredestrant +2 More

Selective Estrogen Receptor Degrader (SERD)

Recruiting1 awardPhase 2
This trial is testing giredestrant, a new drug, to see if it works better than usual hormone treatments for certain breast cancer patients. It targets patients whose cancer grows with the help of estrogen and who have already tried other treatments. The drug aims to block a protein that helps the cancer grow.
Image of University of Miami/Sylvester at Plantation in Plantation, United States.

Retifanlimab +1 More

PD-1 Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new combination therapy for patients with advanced breast cancer who have failed other treatments.
Image of Tranquil Clinical Research in Webster, United States.

(Z)-endoxifen +2 More

Selective Estrogen Receptor Modulator

Recruiting1 awardPhase 2
This trial is testing (Z)-endoxifen, a drug that blocks estrogen, in pre-menopausal women with a specific type of breast cancer. The study aims to see if this drug can slow down cancer growth by measuring a marker called Ki-67. Participants will take the drug daily for several months before surgery.
Image of University of California Los Angeles Medical Center in Los Angeles, United States.

PRO1184

Chemotherapy

Recruiting1 awardPhase 1 & 2
This trial will test the safety, side effects and effectiveness of a new drug (PRO1184) to treat solid tumor cancers.
Image of Georgetown Uni Hospital; 4-N Main Hospital in Washington, United States.

Phesgo

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing a new drug called inavolisib combined with Phesgo, which includes three existing drugs. It targets patients with untreated HER2-positive advanced breast cancer. Inavolisib works by blocking growth signals in cancer cells, while Phesgo targets a protein on these cells to stop their growth and spread.
Image of UC Irvine Health/Chao Family Comprehensive Cancer Center in Orange, United States.

Nab-paclitaxel +2 More

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing how well a combination of chemotherapy drugs, immunotherapy drugs, and a personalized vaccine work in treating patients with metastatic triple negative breast cancer.
Image of SWOG in Portland, United States.

Paclitaxel +3 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial will compare the effects of adding an immunotherapy drug (durvalumab) to usual chemotherapy to usual chemotherapy alone in treating breast cancer.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.